Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows

v3.8.0.1
Condensed Consolidated Statements Of Cash Flows - USD ($)
 6 Months Ended
Mar. 31, 2018
Mar. 31, 2017
OPERATING ACTIVITIES    
Net loss $ (8,088,370) $ (3,142,823)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 88,239 177,444
Amortization of intangible assets 137,631 66,822
Noncash interest expense 350,595  
Share-based compensation 619,302 422,469
Warrants issued   542,930
Deferred income taxes (4,653,558) (1,464,900)
Loss on settlement of accounts receivable 3,764,137  
Change in fair value of derivative liabilities 21,000  
Other (1,942) 4,469
Changes in current assets and liabilities, net of effects of acquisition of a business:    
Decrease in accounts receivable 3,255,107 3,471,625
(Increase) decrease in inventory (821,133) 95,419
(Increase) decrease in prepaid expenses and other assets 58,042 37,313
Increase (decrease) in accounts payable 853,949 (353,223)
Decrease in unearned revenue (142,147)  
Increase (decrease) in accrued expenses and other current liabilities 375,957 (917,542)
Net cash used in operating activities (4,183,191) (1,059,997)
INVESTING ACTIVITIES    
Capital expenditures (1,913) (83,492)
Net cash used in investing activities (1,913) (83,492)
FINANCING ACTIVITIES    
Proceeds from SWK credit agreement 10,000,000  
Payment of debt issuance costs (120,000)  
Net cash used in financing activities 9,880,000  
Net increase (decrease) in cash 5,694,896 (1,143,489)
CASH AT BEGINNING OF PERIOD 3,277,602 2,385,082
CASH AT END OF PERIOD 8,972,498 1,241,593
Schedule of noncash investing and financing activities:    
Issuance of common stock in connection with the APP Acquisition   1,826,097
Issuance of Series 4 Preferred Stock in connection with the APP Acquisition   17,981,883
Reduction of accrued expense upon issuance of shares   22,176
Fixed asset in accounts payable at period end   $ 7,937
Shares issued in connection with common stock purchase agreement 347,081  
Increase in deferred assets from accounts payable and accrued expenses 77,840  
Debt issuance costs in accounts payable and accrued expenses $ 143,943